Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling studyAndrew Clark, Sam Abbott, Christopher I Jarvis et al.|The Lancet Global Health|2020Cited by 1.2k
Vaccine value profile for Group B streptococcusCaroline Trotter, Philipp Lambach, Mark R. Alderson et al.|Vaccine|2023Cited by 37
Neurodevelopmental and growth outcomes after invasive Group B Streptococcus in early infancy: A multi-country matched cohort study in South Africa, Mozambique, India, Kenya, and ArgentinaProma Paul, Jaya Chandna, Simon R. Procter et al.|EClinicalMedicine|2022Cited by 28